ArticleQuantitative biology (Beijing, China)2024

Assessing the inhibition efficacy of clinical drugs against the main proteases of SARS-CoV-2 variants and other coronaviruses.

Wenlong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.